Nath Bio-Genes Current Share Price | Nath Bio-Genes Stock Screener
NATHBIOGEN
Agricultural Products
Nath Bio-Genes Current Stock Price Today
Live Share Price NSE
₹147.34
▼
-0.80 (-0.54%)
Live Share Price BSE
₹148.00
▲
0.10 (0.07%)
As of September 18, 2026, the live Nath Bio-Genes share price (NSE: NATHBIOGEN) is ₹147.34 on NSE and ₹148.00 on BSE, down 0.54% from the previous close, with shares trading between ₹146.50 and ₹149.00 in today's trading session, and a 52-week range of ₹129.02–₹196.01.
Browse NATHBIOGEN balance sheet details to support your investment research.
Use the Nath Bio-Genes stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Nath Bio-Genes Market Cap
₹280.84 Cr.
NATHBIOGEN P/E Ratio (TTM)
7.35
Nath Bio-Genes P/B Ratio
0.42
EPS (TTM)
₹20.98
Dividend Yield
1.34%
Debt to Equity
0.19
NATHBIOGEN 52 Week High
₹196.01
Nath Bio-Genes 52 Week Low
₹129.02
Operating Margin
11.00%
Profit Margin
9.64%
NATHBIOGEN Revenue (TTM)
₹332.00
EBITDA
₹38.00
Net Income
₹32.00
Total Assets
₹1,026.00
Total Equity
₹644.00
Nath Bio-Genes Current Share Price Chart
Track the current Nath Bio-Genes share price and stock price with an interactive chart. Analyse NATHBIOGEN price trends, trading volume, historical performance, and volatility across different timeframes — the complete Nath Bio-Genes stock quote in one place.
Nath Bio-Genes Company Profile - Fundamental Screener
Screen Nath Bio-Genes company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NATHBIOGEN shares.
Sector
FMCG
Industry
Agricultural Products
Sub-Sector
Agricultural Products
Segment
E
ISIN
INE448G01010
Nath Bio-Genes Balance Sheet Screener
Screen NATHBIOGEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 1,026 | 880 | 793 | 740 |
| Current Assets | 690 | 572 | 521 | 468 |
| Fixed Assets | 250 | 250 | 244 | 245 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 17 | 8 | 3 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 644 | 610 | 573 | 542 |
| Share Capital | 19 | 19 | 19 | 19 |
| Reserves & Surplus | 625 | 591 | 554 | 523 |
Nath Bio-Genes Income Statement Screener - Profit & Revenue Analysis
Screen Nath Bio-Genes income statement and profit fundamentals.
Analyze NATHBIOGEN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Nath Bio-Genes share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 332 | 55 | 70 | 48 | 288 | 56 | 37 | 32 | 244 | 44 | 34 | 23 | 235 | 45 | 25 |
| Expenses | 293 | 47 | 62 | 38 | 254 | 52 | 29 | 27 | 207 | 39 | 26 | 18 | 198 | 41 | 20 |
| EBITDA | 38 | 8 | 8 | 10 | 33 | 5 | 9 | 5 | 37 | 5 | 8 | 5 | 37 | 4 | 6 |
| Operating Profit % | 11.00% | 9.00% | 5.00% | 14.00% | 10.00% | 1.00% | 22.00% | 15.00% | 15.00% | 9.00% | 18.00% | 22.00% | 16.00% | 9.00% | 22.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 4 | 5 | 5 | 4 | 3 | 1 | 4 | 3 | 2 | 1 | 3 | 2 | 3 | 2 | 3 |
| Profit Before Tax | 33 | 3 | 3 | 6 | 29 | 2 | 4 | 1 | 34 | 3 | 5 | 2 | 34 | 2 | 2 |
| Tax | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| Net Profit | 32 | 0 | 2 | 5 | 28 | 2 | 3 | 1 | 33 | 3 | 4 | 2 | 33 | 1 | 1 |
| EPS | 16.98 | -0.79 | 0.89 | 2.53 | 14.88 | 0.42 | 1.33 | 0.53 | 17.49 | 1.87 | 2.02 | 0.86 | 17.59 | 0.77 | 0.71 |
Nath Bio-Genes Cash Flow Screener - Liquidity Fundamentals
Screen NATHBIOGEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 18 | 75 | 38 | 17 |
| Investing Activities | -4 | -27 | -3 | -20 |
| Financing Activities | -2 | -8 | -2 | -22 |
| Net Cash Flow | 12 | 39 | 34 | -25 |
Nath Bio-Genes Shareholding Pattern Screener
See Nath Bio-Genes shareholding pattern with promoter, FII, and DII holdings.
Check Nath Bio-Genes promoter holding and ownership changes for NATHBIOGEN on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% |
| FII Holding | 0.23% | 0.27% | 0.21% | 0.42% | 0.32% | 0.31% | 0.27% | 0.22% |
| DII Holding | 0.01% | 0.01% | 3.94% | 2.25% | 0.76% | 0.01% | 4.37% | 4.38% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 34.39% | 34.37% | 31.94% | 32.98% | 33.78% | 34.22% | 32.25% | 32.43% |
| Other Holding | 19.77% | 19.76% | 18.31% | 18.76% | 19.54% | 19.87% | 17.51% | 17.39% |
| Shareholder Count | 33,031 | 32,564 | 34,911 | 34,207 | 34,122 | 33,550 | 35,132 | 35,834 |
Nath Bio-Genes Share Dividend Screener - Share Yield Analysis
Check Nath Bio-Genes dividend history with payout and yield data.
View Nath Bio-Genes dividend details including ex-dates and amounts for NATHBIOGEN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 1.55% |
| 2024-March | ₹2.00 | 1.37% |
| 2023-March | ₹2.00 | 1.15% |
| 2022-March | ₹2.00 | 1.43% |
| 2021-March | ₹2.00 | 0.94% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Nath Bio-Genes Stock Index Membership
See which indices include Nath Bio-Genes stock.
Check NATHBIOGEN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Nath Bio-Genes Market Events Screener - Corporate Actions
Get Nath Bio-Genes corporate actions including splits, bonuses, and buybacks.
Check Nath Bio-Genes stock events that may affect NATHBIOGEN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-24 | 2026-09-24 | Annual General Meeting | NA | -9.81% |
| 2026-09-11 | 2026-09-11 | Dividend | ₹ 2.00 /share | -22.19% |
| 2026-07-29 | 2026-07-29 | Quarterly Result Announcement | NA | 2.62% |
| 2026-05-04 | 2026-05-04 | Quarterly Result Announcement | NA | 15.91% |
| 2026-01-31 | 2026-01-31 | Quarterly Result Announcement | NA | 4.05% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -3.84% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | 11.30% |
| 2025-08-14 | 2025-08-14 | Dividend | ₹ 2.00 /share | 10.58% |
| 2025-07-11 | 2025-07-11 | Quarterly Result Announcement | NA | 7.96% |
| 2025-04-29 | 2025-04-29 | Quarterly Result Announcement | NA | -5.95% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | 0.03% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -3.45% |
| 2024-08-17 | 2024-08-17 | Annual General Meeting | NA | 8.77% |
| 2024-08-09 | 2024-08-09 | Dividend | ₹ 2.00 /share | 12.01% |
| 2024-03-12 | 2024-03-12 | Extraordinary General Meeting | NA | -11.30% |
Nath Bio-Genes Competitors Screener - Peer Comparison
Screen NATHBIOGEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LT Foods | 15,213 | 23.97 | 10,946 | 24.81% | 613 | 52.67 |
| KRBL | 9,637 | 12.78 | 6,168 | 9.07% | 648 | 55.72 |
| Gujarat Ambuja Exports | 7,480 | 18.21 | 5,836 | 24.30% | 304 | 43.07 |
| Kaveri Seed Company | 3,682 | 14.88 | 1,395 | 11.46% | 290 | 26.85 |
| Trualt Bioenergy | 3,570 | 22.53 | 1,814 | -7.85% | 97 | 34.69 |
| Sanstar | 2,214 | 62.50 | 785 | -27.46% | 35 | 51.78 |
| Amir Chand Jagdish Kumar (Exports) | 2,124 | 17.27 | 2,287 | 14.13% | 103 | 67.95 |
| GRM Overseas | 1,750 | 23.73 | 1,769 | 28.74% | 76 | 38.63 |
| Chaman Lal Setia Exports | 1,474 | 12.02 | 1,440 | -4.28% | 114 | 50.34 |
| Avt Natural Products | 1,373 | 16.52 | 727 | 27.04% | 65 | 61.81 |
Nath Bio-Genes Company Announcements - News Screener
Screen NATHBIOGEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-10 | Corporate Action-Board to consider Dividend | - |
| 2026-09-09 | Corporate Action-Board to consider Dividend | - |
| 2026-09-01 | Record Date | - |
| 2026-09-01 | Reg. 34 (1) Annual Report. | - |
| 2026-09-01 | Intimation Of Annual General Meeting | - |
| 2026-08-06 | Announcement Under Reg 30 Of SEBI (LODR) | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-07-29 | Financial Results As Of 30Th June 2026. | - |
| 2026-07-23 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-18 | Board Meeting Intimation for Approval Of Financial Results | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-28 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-11 | NBIL Concall | - |
| 2026-05-11 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-05-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-04 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-05-04 | Outcome Of Board Meeting | - |
| 2026-04-29 | Intimation Of Conference Call | - |
| 2026-04-25 | Board Meeting Intimation for Approval Of Financial Results As On 31St March 2026. | - |